Recompete Brief

Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of England

Priority 95/100Engage now
BuyerNHS England
Current supplierAVENTIS PHARMA LIMITED t-a Sanofi,BIOGEN IDEC LIMITED,ACCORD-UK LTD
Published value£35,312,548
Expiry31 Aug 2027
Recommended move
Engage now
Start buyer research and early engagement now.
Priority 95/100 · Data confidence 87/100

Why this opportunity deserves a look

345 days to recorded expiry
5 previous procurements found
7 historical suppliers found